Updates
Working from Home and Alcohol Use
This study examined the associations between working at home and alcohol consumption. Using data from a pre-COVID-19 sample, information was collected between 2004 and 2019 from a large cross-sectional sample of Norwegian employees. Working at home greater than 15...
Study: Increased Risk for COVID-19 Breakthrough Infection in Fully Vaccinated Patients with SUDs
Though vaccines are highly effective against COVID-19, their effectiveness in individuals with substance use disorders (SUD) might also be limited by greater exposure to infection, added to the already waning vaccine immunity and new variants. This population-based...
Controlled Substance Reporting System (CSRS) Support for Bidirectional EHR Connection
The North Carolina Department of Health and Human Services (NC DHHS) will cover the licensing fees associated with the integration service for approved prescribers and pharmacists in North Carolina to connect their EHR to PMP Gateway and NarxCare. Additional fees, in...
DEA Issues Public Safety Alert Regarding Potentially Lethal Fake Prescription Pills
The Drug Enforcement Administration (DEA) has issued a Public Safety Alert warning Americans of a sharp increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. The DEA’s last Public Safety Alert came nearly seven...
Updated NC Statewide Overdose Surveillance Reports – August 2021
The Injury and Violence Prevention Branch of the Division of Public Health recently updated provisional data on suspected opioid overdose EMS encounters and ED visits for opioid-related overdose and unintentional med/drug with potential for abuse overdose for August...
Black Patients Prescribed Fewer Opioids than White Patients in Same Health System
Health care is rife with inequities, from access to quality of care, and a new study finds that common opioids such as codeine and morphine are more often prescribed to white patients than to Black patients treated within the same health system. White patients...
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.